A smooth and uninterrupted cold chain is vital to reliable pharmaceutical logistics. Many pharmaceutical products are very sensitive to even the slightest fluctuations in temperature, and some can even lose efficacy. This makes well-trained staff essential, alongside high-performance warehouses with stable refrigeration and cooling options.
“In the course of the certification process, the FCS special warehouses were equipped with a state-of-the-art new temperature monitoring system and underwent an in-depth audit. Functionality and safety for the products was confirmed by the necessary temperature mapping activities,” says Christoph Cyranek, Manager Quality Assurance & Performance Improvement at FCS. “As part of our preparations for the logistics involving Covid-19 vaccines that is presumably coming up, this certification comes at just the right time, of course. As the first step, we already decided to expand our existing infrastructure so even more handling space can be provided for active refrigerated containers,” he notes.
The next big step, what is known as GDP certification, is also coming up soon. EU “good distribution practice” (GDP) certification for medical products for human use, like CEIV certification, serves to monitor the distribution chain with an eye to the quality and intactness of medicinal products. Unlike CEIV certification, however, it addresses a larger segment of the economy, since GDP certification relates to the entire process of transportation from the producer through to the end customer, independent of airfreight.
Working in tandem with other companies based at Frankfurt Airport that also have CEIV certification, like Fraport Ground Services, a safe, high-quality transportation chain at Frankfurt Airport can be ensured between cargo and apron handlers and airlines. This makes Frankfurt Airport even more attractive as a transshipment point for the pharmaceutical industry, which is especially strong in Germany.